Delivery Order 75F40124D00042-75F40125F19001

Award Date 5/20/25
Potential Completion Date 9/29/25
Potential Value $1.4M
Ultimate Awardee
CVS Health Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Hartford, CT 06156, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, Food and Drug Administration awarded a $24,519,103.59 Delivery Order contract to CVS Health Clinical Trial Services LLC, a subsidiary of CVS Health Corporation. The contract supports the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS, which involves providing data sources and conducting surveillance of biological drug safety. The contract is a Time and Materials type with a period of performance...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...
This is a $8,614,570.87 delivery order contract awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc., a non-profit healthcare organization. The contract supports the FDA's Sentinel System for post-market medical product safety surveillance, including developing and maintaining the Sentinel Innovation Center and conducting comprehensive data analytics projects. The contract is not set-aside. Harvard Pilgrim Health Care Inc. has established itself as a critical...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle. The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work...
This is a federal contract award from the National Institutes of Health (NIH) Clinical Center to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $77,262.73, is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices. The award is a delivery order contract with a firm-fixed price pricing type, and it has an ultimate completion date of August 17, 2020. This...
This is a federal contract award issued by the National Institutes of Health (NIH) Clinical Center to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $98,365.27, is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, with a...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,596 delivery order contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a...
This federal contract award, valued at $97,874.92, was issued by the Office of the Chief Operating Officer, a civilian agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. The contract covers the delivery of a broad range of pharmaceutical products and medical supplies,...
This is a federal contract award issued by the National Institutes of Health (NIH) Clinical Center to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $89,527.03, is a Firm Fixed Price Delivery Order that does not have a set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support...
This is a $83,607.88 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Office of the Chief Operating Officer of the Department of Health and Human Services. The contract is for the provision of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support federal healthcare...
  • 75F40124D00042
    Indefinite Delivery Contract
  • 75F40124D00042-75F40125F19001
    Delivery Order

This is a $1,381,573.96 time-and-materials delivery order awarded by the Food and Drug Administration (FDA) to CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation. The contract supports the FDA's Biologics Effectiveness and Safety (BEST) Initiative #3 for healthcare data sources to monitor biologics safety surveillance. The work will be performed in Hartford, CT. No set-aside was used for this award. As a parent company, CVS Health Corporation has secured numerous federal contracts to provide pharmaceutical products and research services to various government agencies, but this award is specifically to the CVS Healthspire Payor & Life Sciences subsidiary to provide data analytics and surveillance support for the BEST program, which aims to enhance post-market monitoring of biological drug safety.

Generated 5/21/25, 10:06 AM